On the contrary, in a study by Santric on Serbian subjects [111], carriers of homozygous GSTO1*A/A (rs4925; D/D) and GSTO2*G/G (rs156697; D/D) variant genotypes had a higher risk of developing prostatic cancer, but no association with overall survival was found. Here, GSTO1 is linked to prostate carcinoma.